On Monday the FDA ordered the seizure of 23,000 bottles of dietary supplements which had been marketed as body building aids. The agency was quoted as saying:

?There is inadequate information to assure that the ingredients do not present a significant or unreasonable risk of illness or injury.?

According to laboratory tests, the FDA found that the products in question (sold under the brand names Methyl 1-D, Methyl 1-D XL, and Formadrol Extreme XL) contained one or more unapproved food additives and/or ingredients about which there is not enough information.

Methyl 1-D and Methyl 1-D XL contained 1,4,6-androstatriene-3,17-dione (ATD), while Formadrol Extreme XL supplement product contained ATD and 3,6,17-androstenetrione (6-OXO). The seized supplements were valued at an estimated $1.3 million.

The agency stated that they possessed no scientific information concerning the safety of the condemned products of their ingredients.

FDA News: Federal Agents Seize Nearly $1.3 Million of Illegal Dietary Supplements

Coming on the heels of the recent Hydroxycut recall, it would appear that the FDA is aiming to take a more pro-active stance regarding dietary supplements. Recent press surrounding these two incidents have once again stirred up DSHEA opponents. Listen to the interview below to hear Dr. George L. Blackburn, Division Associate Director of Harvard Medical School, and Natural Products Association CEO David Seckman discuss the coming challenges facing the industry in the fall-out of these the Hydroxycut recall.